Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125483682 | 12548368 | 2 | F | 20160728 | 20160712 | 20160801 | EXP | PHJP2016JP019588 | NOVARTIS | 5.00 | YR | F | Y | 0.00000 | 20160802 | MD | COUNTRY NOT SPECIFIED | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125483682 | 12548368 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 100 MG, UNK | 16608 | 100 | MG | GRANULATE | |||||||
| 125483682 | 12548368 | 2 | C | E KEPPRA | LEVETIRACETAM | 1 | Oral | 900 MG, UNK | 0 | 900 | MG | DRY SYRUP | |||||||
| 125483682 | 12548368 | 3 | C | E KEPPRA | LEVETIRACETAM | 1 | Oral | 1000 MG, UNK | 0 | 1000 | MG | DRY SYRUP |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125483682 | 12548368 | 1 | Product used for unknown indication |
| 125483682 | 12548368 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125483682 | 12548368 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125483682 | 12548368 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125483682 | 12548368 | 1 | 20160708 | 0 | ||
| 125483682 | 12548368 | 3 | 20160708 | 0 |